Norepinephrine and Vasopressin in Hemorrhagic Shock: A Focus on Renal Hemodynamics
- PMID: 36835514
- PMCID: PMC9967703
- DOI: 10.3390/ijms24044103
Norepinephrine and Vasopressin in Hemorrhagic Shock: A Focus on Renal Hemodynamics
Abstract
During hemorrhagic shock, blood loss causes a fall in blood pressure, decreases cardiac output, and, consequently, O2 transport. The current guidelines recommend the administration of vasopressors in addition to fluids to maintain arterial pressure when life-threatening hypotension occurs in order to prevent the risk of organ failure, especially acute kidney injury. However, different vasopressors exert variable effects on the kidney, depending on the nature and dose of the substance chosen as follows: Norepinephrine increases mean arterial pressure both via its α-1-mediated vasoconstriction leading to increased systemic vascular resistance and its β1-related increase in cardiac output. Vasopressin, through activation of V1-a receptors, induces vasoconstriction, thus increasing mean arterial pressure. In addition, these vasopressors have the following different effects on renal hemodynamics: Norepinephrine constricts both the afferent and efferent arterioles, whereas vasopressin exerts its vasoconstrictor properties mainly on the efferent arteriole. Therefore, this narrative review discusses the current knowledge of the renal hemodynamic effects of norepinephrine and vasopressin during hemorrhagic shock.
Keywords: hemodynamics; hemorrhagic shock; ischemia/reperfusion; kidney; norepinephrine; renal hemodynamics; renal perfusion; vasopressin; vasopressor.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Differing effects of epinephrine, norepinephrine, and vasopressin on survival in a canine model of septic shock.Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2545-54. doi: 10.1152/ajpheart.00450.2004. Epub 2004 Aug 19. Am J Physiol Heart Circ Physiol. 2004. PMID: 15319205
-
Beneficial effects of short-term vasopressin infusion during severe septic shock.Anesthesiology. 2002 Mar;96(3):576-82. doi: 10.1097/00000542-200203000-00011. Anesthesiology. 2002. PMID: 11873030 Clinical Trial.
-
Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.J Intensive Care Med. 2019 Sep;34(9):761-765. doi: 10.1177/0885066617716396. Epub 2017 Jul 28. J Intensive Care Med. 2019. PMID: 28750598
-
Physiology of vasopressin relevant to management of septic shock.Chest. 2001 Sep;120(3):989-1002. doi: 10.1378/chest.120.3.989. Chest. 2001. PMID: 11555538 Review.
-
Vasopressin: physiology and clinical use in patients with vasodilatory shock: a review.Neth J Med. 2005 Jan;63(1):4-13. Neth J Med. 2005. PMID: 15719846 Review.
Cited by
-
Therapeutic Potential of Centhaquine Citrate, a Selective Alpha-2B Adrenoceptor Agonist, in the Management of Circulatory Shock.Drugs. 2025 Jun;85(6):777-799. doi: 10.1007/s40265-025-02176-y. Epub 2025 Apr 20. Drugs. 2025. PMID: 40253656 Free PMC article. Review.
-
Machine learning for risk prediction of acute kidney injury in patients with diabetes mellitus combined with heart failure during hospitalization.Sci Rep. 2025 Mar 28;15(1):10728. doi: 10.1038/s41598-025-87268-1. Sci Rep. 2025. PMID: 40155666 Free PMC article.
-
Effects of Vasopressin Receptor Agonists during the Resuscitation of Hemorrhagic Shock: A Systematic Review and Meta-Analysis of Experimental and Clinical Studies.J Pers Med. 2023 Jul 16;13(7):1143. doi: 10.3390/jpm13071143. J Pers Med. 2023. PMID: 37511756 Free PMC article.
-
An Update on Pharmacologic Management of Neonatal Hypotension: When, Why, and Which Medication.Children (Basel). 2024 Apr 19;11(4):490. doi: 10.3390/children11040490. Children (Basel). 2024. PMID: 38671707 Free PMC article. Review.
-
Navigating Hemorrhagic Shock: Biomarkers, Therapies, and Challenges in Clinical Care.Biomedicines. 2024 Dec 17;12(12):2864. doi: 10.3390/biomedicines12122864. Biomedicines. 2024. PMID: 39767770 Free PMC article. Review.
References
-
- Spahn D.R., Bouillon B., Cerny V., Duranteau J., Filipescu D., Hunt B.J., Komadina R., Maegele M., Nardi G., Riddez L., et al. The European guideline on management of major bleeding and coagulopathy following trauma: Fifth edition. Crit. Care. 2019;23:98. doi: 10.1186/s13054-019-2347-3. - DOI - PMC - PubMed
-
- Douzinas E.E., Livaditi O., Tasoulis M.-K., Prigouris P., Bakos D., Goutas N., Vlachodimitropoulos D., Andrianakis I., Betrosian A., Tsoukalas G.D. Nitrosative and Oxidative Stresses Contribute to Post-Ischemic Liver Injury Following Severe Hemorrhagic Shock: The Role of Hypoxemic Resuscitation. PLoS ONE. 2012;7:e32968. doi: 10.1371/journal.pone.0032968. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources